ClinicalTrials.Veeva

Menu

Acclimatization Mechanisms During Ascent to 7500m

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

Acute Mountain Sickness

Treatments

Behavioral: ascent protocol

Study type

Interventional

Funder types

Other

Identifiers

NCT00603122
EK-1189
SNSF 3200B0-108300

Details and patient eligibility

About

The trial evaluates the role of ascent protocol on acute mountain sickness and cardio-respiratory physiology during an ascent to Muztagh Ata (7546m). Two groups of mountaineers ascend with different acclimatization time to the summit. The prevalence and severity of symptoms of acute mountain sickness are evaluated along with physiologic variables.

Enrollment

37 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy, physically fit subject
  • Mountaineering experience

Exclusion criteria

  • Any type of cardiac or respiratory disease
  • Regular intake of any medication
  • History of high altitude pulmonary oedema
  • Severe acute mountain sickness at altitudes below 3500m or high altitude cerebral oedema.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

37 participants in 2 patient groups

1
Experimental group
Description:
fast ascent
Treatment:
Behavioral: ascent protocol
2
Active Comparator group
Description:
slow ascent
Treatment:
Behavioral: ascent protocol

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems